X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (9) 9
index medicus (8) 8
cancer (7) 7
female (6) 6
humans (6) 6
male (6) 6
middle aged (6) 6
aged (5) 5
tumors (5) 5
adult (4) 4
care and treatment (4) 4
chemotherapy (4) 4
medical research (4) 4
medicine & public health (4) 4
medicine, experimental (4) 4
pharmacokinetics (4) 4
treatment outcome (4) 4
antineoplastic agents - adverse effects (3) 3
antineoplastic agents - pharmacokinetics (3) 3
antineoplastic agents - therapeutic use (3) 3
cancer research (3) 3
cancer therapies (3) 3
diarrhea (3) 3
esophageal cancer (3) 3
neoplasms - drug therapy (3) 3
pharmacology & pharmacy (3) 3
pharmacology/toxicology (3) 3
studies (3) 3
toxicity (3) 3
trial (3) 3
aged, 80 and over (2) 2
analysis (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
asian continental ancestry group (2) 2
cancer patients (2) 2
carcinoma (2) 2
combination (2) 2
disease-free survival (2) 2
docetaxel (2) 2
dose-response relationship, drug (2) 2
drug administration schedule (2) 2
esophagus (2) 2
fluorouracil (2) 2
gastric cancer (2) 2
immunoglobulin g (2) 2
japan (2) 2
japanese (2) 2
kinases (2) 2
ligands (2) 2
maximum tolerated dose (2) 2
medical prognosis (2) 2
metastasis (2) 2
mutations (2) 2
neoplasms - blood (2) 2
neutropenia (2) 2
original (2) 2
original article (2) 2
paclitaxel (2) 2
paclitaxel - administration & dosage (2) 2
paclitaxel - adverse effects (2) 2
patients (2) 2
pharmacology (2) 2
pyrazoles - therapeutic use (2) 2
s-1 (2) 2
safety (2) 2
solid tumors (2) 2
stomach cancer (2) 2
stomach neoplasms - drug therapy (2) 2
2nd-line chemotherapy (1) 1
3-hour infusion (1) 1
5-fluorouracil (1) 1
5-fluorouracil + cisplatin (1) 1
5-fluorouracil plus cisplatin (1) 1
5-fu (1) 1
abemaciclib (1) 1
aberration (1) 1
adenocarcinoma (1) 1
adenosquamous (1) 1
adjuvant chemotherapy (1) 1
advanced breast-cancer (1) 1
advanced cancer (1) 1
advanced solid tumors (1) 1
akt inhibitor (1) 1
akt protein (1) 1
albumin (1) 1
alcohol (1) 1
aminopyridines - administration & dosage (1) 1
aminopyridines - adverse effects (1) 1
aminopyridines - pharmacokinetics (1) 1
amplification (1) 1
anemia (1) 1
anemia - chemically induced (1) 1
anemia - epidemiology (1) 1
anorexia - chemically induced (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibody-dependent cellular cytotoxicity (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - blood (1) 1
antineoplastic agents/adverse effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 631 - 639
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2017, Volume 140, Issue 1, pp. 188 - 196
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 8/2016, Volume 78, Issue 2, pp. 281 - 288
Journal Article
Investigational New Drugs, ISSN 0167-6997, 8/2017, Volume 35, Issue 4, pp. 451 - 462
Background AZD4547 is a potent, oral, highly selective fibroblast growth factor receptor (FGFR) inhibitor in clinical development for treating tumours with a... 
AZD4547 | Phase I | Medicine & Public Health | Oncology | Safety | Pharmacology/Toxicology | Pharmacokinetics | FGFR | Japanese | PLACEBO | PAZOPANIB | EFFICACY | CELL LUNG-CANCER | TRIAL | INTERFERON-ALPHA | AMPLIFICATION | ONCOLOGY | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | MUTATIONS | SOFT-TISSUE SARCOMA | Neoplasms - metabolism | Pyrazoles - therapeutic use | Benzamides - pharmacokinetics | Humans | Middle Aged | Half-Life | Male | Antineoplastic Agents - therapeutic use | Benzamides - therapeutic use | Neoplasms - blood | Antineoplastic Agents - adverse effects | Pyrazoles - blood | Adult | Female | Antineoplastic Agents - pharmacokinetics | Piperazines - pharmacokinetics | Piperazines - blood | Pyrazoles - pharmacokinetics | Benzamides - adverse effects | Pyrazoles - adverse effects | Benzamides - blood | Receptors, Fibroblast Growth Factor - antagonists & inhibitors | Treatment Outcome | Piperazines - therapeutic use | Piperazines - adverse effects | Neoplasms - drug therapy | Asian Continental Ancestry Group | Antineoplastic Agents - blood | Aged | Care and treatment | Physiological aspects | Dosage and administration | Research | Health aspects | Antineoplastic antibiotics | Tumors | Fibroblast growth factor receptors | Fibroblast growth factor | Toxicity | Fluorescence | Dosage | Quality | Fluorescence in situ hybridization | Fibroblasts | Growth factors | Neutropenia | Dosing | Diarrhea | Radioactive half-life | Nausea | Pharmacology | Patients | Steady state | Studies | Stomatitis | Inhibitors | Aberration | Mutation | Index Medicus | Phase I Studies
Journal Article
Cancer Science, ISSN 1347-9032, 10/2018, Volume 109, Issue 10, pp. 3216 - 3223
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.